The biotech, which earlier this year laid off nearly all of its staff, also announced a PIPE that will hand it $175 million ...

AstraZeneca could spend up to $5.3 billion in a deal to develop oral medicines with CSPC Pharmaceutical. Elsewhere, Insmed cashed in on a stock surge and Third Harmonic kicked off a drug auction.

THIRD HARMONIC BIO posted quarterly earnings results on Thursday, May 8th.The company reported earnings of -$0.35 per share, missing estimates of -$0.30 by $0.05. The company also reported revenue ...

Third Harmonic Bio, Inc. (NASDAQ:THRD) is a biopharmaceutical company. The one-month return of Third Harmonic Bio, Inc. (NASDAQ:THRD) was 48.28%, and its shares lost 55.90% of their value over the ...

On April 21, 2025, Third Harmonic Bio, Inc. announced that its Chief Scientific Officer, Christopher Dinsmore, would step down from his position effective immediately. As part of a separation ...

Third Harmonic Bio shares were up 39%, trading around $5.06 at the time of publication Monday, according to Benzinga Pro. Read Next: S&P 500 Could Tank To 4,000 If ‘Trump Put’ Fizzles, Says ...

Third Harmonic Bio expects to distribute approximately $246.6 million to $259.8 million to its shareholders, which translates to about $5.13 to $5.42 per share.

Fintel reports that on March 28, 2025, Stifel downgraded their outlook for Third Harmonic Bio (NasdaqGM:THRD) from Buy to Hold. Analyst Price Forecast Suggests 166.69% Upside As of March 19, 2025 ...

Third Harmonic Bio, Inc. (THRD) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

On Tuesday, Third Harmonic Bio, Inc. (NASDAQ:THRD) revealed results from its Phase 1 single and multiple ascending dose (SAD/MAD) trial of THB335 in healthy volunteers. The company says the data ...

THB335 showed dose-dependent serum tryptase reductions from 13% to 84% at Day 15, supporting its advancement to Phase 2 in CSU. Third Harmonic Bio will halt non-THB335 research and cut 50% of its ...